<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01305785</url>
  </required_header>
  <id_info>
    <org_study_id>AMIS Plus</org_study_id>
    <nct_id>NCT01305785</nct_id>
  </id_info>
  <brief_title>AMIS Plus - National Registry of Acute Myocardial Infarction in Switzerland</brief_title>
  <acronym>AMIS Plus</acronym>
  <official_title>National Registry of Acute Myocardial Infarction in Switzerland</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Luzerner Kantonsspital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Triemli Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kantonsspital Baden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cantonal Hospital of St. Gallen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Freiburg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cantonal Hospital, Frauenfeld</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Centre Biel/Bienne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Spital Lachen AG</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cardiocentro Ticino</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Luzerner Kantonsspital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The AMIS Plus national registry collects and analyzes data on patients with acute myocardial&#xD;
      infarction in Switzerland in the pre-admission, hospital and follow-up phases. Emphasis is&#xD;
      placed on the evaluation of risk factors, diagnostics, urgent therapy strategies and&#xD;
      treatment of acute coronary syndrome. The AMIS Plus data gathered are important for assessing&#xD;
      guidelines, improving compliance with guidelines in clinical practice, investigating patient&#xD;
      groups not extensively studied in large randomized trials, quality assurance as well as the&#xD;
      continuous improvement of therapeutic strategies based on a large database.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The AMIS Plus project has two main goals:&#xD;
&#xD;
        1. To Maintain a Nationwide Registry&#xD;
&#xD;
             -  An ongoing nationwide registry (databank) of acute coronary syndromes&#xD;
&#xD;
             -  Description of the patient population with acute coronary syndromes&#xD;
&#xD;
             -  Description of characteristics of treatment and hospitalization&#xD;
&#xD;
             -  Description of outcomes 3- and 12-months after admission for ACS&#xD;
&#xD;
             -  Epidemiological studies, e.g. definition of risk factors of patients with acute&#xD;
                coronary syndromes, hospital mortality, time and cost-effective strategies as well&#xD;
                as outcome measures&#xD;
&#xD;
        2. Quality Control&#xD;
&#xD;
             -  Evaluation of compliance with guidelines for the medical care of acute coronary&#xD;
                syndromes&#xD;
&#xD;
             -  Internal quality control through regular feedback and benchmarking&#xD;
&#xD;
      Methods&#xD;
&#xD;
      All Swiss hospitals admitting patients with acute coronary syndrome are eligible. Data are&#xD;
      collected on demographics, risk factors, symptoms, laboratory results, invasive therapy,&#xD;
      complications and medication.&#xD;
&#xD;
      Since the start in January 1997, the method of data collection has continuously improved in&#xD;
      order to suit the different needs and technological advancements of the participating&#xD;
      hospitals. Participants can either complete paper questionnaires and send them directly to&#xD;
      the AMIS Plus Data Center at the Institute of Social and Preventive Medicine in Zurich where&#xD;
      these questionnaires are then checked and entered online or they can enter data directly&#xD;
      online (AMIS online questionnaire). Data security has a high priority. Participant&#xD;
      identification (code for hospital and physician) and a password are required to access the&#xD;
      data entry form and send data.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 1997</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">60000</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Acute myocardial infarction definition:&#xD;
&#xD;
          1. Characteristic ischemic symptoms&#xD;
&#xD;
          2. ECG changes indicating new ischemia (ST-T changes or new left bundle branch block) or&#xD;
             developing pathological Q-waves&#xD;
&#xD;
          3. A dynamic increase or decrease in biomarker or troponin (I or T) levels above the&#xD;
             individual hospital cut-off for MI. The internationally accepted guidelines for&#xD;
             troponin levels are set at least one value above the 99th percentile of the upper&#xD;
             reference limit (URL). Cut-off levels for either total creatine kinase (CK) or&#xD;
             creatine kinase MB fraction (CK-MB) at least twice the upper limit of normal.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: Patients who had symptoms within the last 48 hours at hospital&#xD;
        admission with a discharge clinical diagnosis of acute myocardial infarction or patients&#xD;
        who suffered an acute myocardial infarction in hospital during a hospitalization for other&#xD;
        reasons.&#xD;
&#xD;
        Exclusion Criteria: Since January 2012, patients with unstable angina are no longer&#xD;
        included.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Erne, MD</last_name>
    <role>Study Director</role>
    <affiliation>AMIS Plus Data Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paul Erne, MD</last_name>
    <phone>++41 41 205 51 06</phone>
    <email>Paul.Erne@luks.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Zurich</name>
      <address>
        <city>Zurich</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dragana Radovanovic</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <link>
    <url>http://www.amis-plus.ch</url>
    <description>AMIS Plus Registry</description>
  </link>
  <results_reference>
    <citation>Radovanovic D, Erne P. AMIS Plus: Swiss registry of acute coronary syndrome. Heart. 2010 Jun;96(12):917-21. doi: 10.1136/hrt.2009.192302.</citation>
    <PMID>20538666</PMID>
  </results_reference>
  <verification_date>April 2013</verification_date>
  <study_first_submitted>February 28, 2011</study_first_submitted>
  <study_first_submitted_qc>February 28, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 1, 2011</study_first_posted>
  <last_update_submitted>April 16, 2013</last_update_submitted>
  <last_update_submitted_qc>April 16, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 17, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Luzerner Kantonsspital</investigator_affiliation>
    <investigator_full_name>Prof. Paul Erne</investigator_full_name>
    <investigator_title>AMIS Plus Steering Committee President</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

